In lung cancer, the loss of BRG1 or BRM components of the SWI/SNF chromatin remodeling complex activates the NRF2 signaling pathway, particularly increasing the expression of NRF2 target genes HMOX1 and GSTM4. Here, NFE2L2 is linked to lung carcinoma.